Ernexa Therapeutics Inc. Warrants Stock Performance

Open $0.03	Prev. Close $0.04	Circuit Range N/A
Day Range $0.03 - $0.03	Year Range $0.02 - $0.18	Volume 4,200
Average Traded $0.03

Ernexa Therapeutics Inc. Warrants Share Price Today

As of 9 October 2026, Ernexa Therapeutics Inc. Warrants's share price is $0.03. The stock opened at $0.03, compared to its previous close of $0.04. During today's trading session, Ernexa Therapeutics Inc. Warrants's share price traded between $0.03 and $0.03, with an average price of $0.03. Over the past 52 weeks, the stock has recorded a high of $0.18 and a low of $0.02. In terms of performance, Ernexa Therapeutics Inc. Warrants's share price has declined by 71.00% over the last six months and is down 71.00% on a year-on-year basis.

Ernexa Therapeutics Inc. Warrants Share Price Chart

$0.03$0.03

Ernexa Therapeutics Inc. Warrants Stock Fundamentals & Key Indicators

Market Cap $164612.70	PE Ratio (TTM) N/A	Dividend Yield N/A
EPS (TTM) N/A	Revenue (TTM) N/A	Return On Equity (TTM) -383.53%
Profit Margin N/A	Debt to Equity 0.00	Quarterly Earnings Growth YoY N/A

Ernexa Therapeutics Inc. Warrants Quarterly Profit & Loss

All figures in USD

Particulars	Mar 2026	Jun 2026
Revenue	$0.00	$0.00
Net Profit	-$5.51	-$4.02
Net Profit Margin	N/A	N/A
Income Change	N/A	27.04%

About Ernexa Therapeutics Inc. Warrants

Ernexa Therapeutics Inc is a preclinical-stage synthetic allogeneic iMSC therapy company developing medicines to treat various forms of cancer and other diseases with high unmet medical needs. Its main product candidate, ERNA-101, capitalizes on the intrinsic tumor-homing ability of MSCs (mesenchymal stem cells) to slip through the tumor's defenses and to deliver potent pro-inflammatory factors directly to the tumor microenvironment. The firm's initial focus is to develop ERNA-101 in platinum-resistant ovarian cancer. Through another product candidate, ERNA-201, it is investigating anti-inflammatory cytokine (IL-10) secreting iMSCs in autoimmune disorders like rheumatoid arthritis. The company operates in a single reportable segment, the research and development of cellular therapies.

Ernexa Therapeutics Inc. Warrants Historical Returns

Month	Open	Close	Change %
Oct 2026	$0.03	$0.03	-27.78%
Sep 2026	$0.05	$0.04	-28.00%
Jul 2026	$0.07	$0.05	-20.63%
Jun 2026	$0.13	$0.06	-57.72%
May 2026	$0.10	$0.15	+217.02%
Mar 2026	$0.08	$0.05	-47.78%
Feb 2026	$0.06	$0.09	N/A

ERNAW Share Price FAQs

What is Ernexa Therapeutics Inc. Warrants share price today?

Ernexa Therapeutics Inc. Warrants share price today is $0.03 as on October 6, 2026 at 9:24 pm IST.

What is the 52 week high and 52 week low of Ernexa Therapeutics Inc. Warrants stock?

The 52 week high of Ernexa Therapeutics Inc. Warrants stock is $0.18, while the 52 week low is $0.02 as of 6 Oct '26.

What is ERNAW's market capitalisation today?

ERNAW market capitalisation is $164612.70 as of October 9, 2026, at 6:23 am IST.

What is ERNAW's net income for the last quarter?

ERNAW's net income for the last quarter is -4.02B USD.

What is the 5 year returns of ERNAW?

The 5 year returns of ERNAW is -71.00% as on 6 Oct '26.

What is the high & low stock price of ERNAW today?

ERNAW stock price hit a high of $0.03 and low of $0.03 as of 6 Oct '26.

Can I buy ERNAW shares in India?

Yes. You can buy ERNAW in India by opening an international trading account.